Viewing Study NCT00061750


Ignite Creation Date: 2025-12-24 @ 5:16 PM
Ignite Modification Date: 2025-12-30 @ 7:46 PM
Study NCT ID: NCT00061750
Status: COMPLETED
Last Update Posted: 2012-04-19
First Post: 2003-06-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module